BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 4916084)

  • 1. Endocrine treatment of cancer of the prostate.
    Madsen PO; Pedersen JF; Knuth OE
    Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormone therapy of cancer of the prostate gland].
    Madsen PO; Pedersen IF; Knut OE
    Urol Nefrol (Mosk); 1970; 35(3):25-8. PubMed ID: 4915239
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution on the clinical aspects of prostatic carcinoma].
    Sladczyk E
    Z Arztl Fortbild (Jena); 1967 Jul; 61(13):657-60. PubMed ID: 5598256
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.
    Surg Gynecol Obstet; 1967 May; 124(5):1011-7. PubMed ID: 6022476
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic usefulness of serum acid phosphatase levels in carcinoma of the prostate.
    Ishibe T; Usui T; Nihira H
    J Urol; 1974 Aug; 112(2):237-40. PubMed ID: 4843340
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer of the prostate.
    N Engl J Med; 1968 Apr; 278(15):848-9. PubMed ID: 5642506
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo.
    Bailar JC; Byar DP
    Cancer; 1970 Aug; 26(2):257-61. PubMed ID: 4916020
    [No Abstract]   [Full Text] [Related]  

  • 8. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
    Gleason DF; Mellinger GT
    J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate.
    Blackard CE; Doe RP; Mellinger GT; Byar DP
    Cancer; 1970 Aug; 26(2):249-56. PubMed ID: 4916019
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of estrogen therapy on metastatic carcinoma of the prostate.
    Anikwe RM
    Int Surg; 1977 Oct; 62(10):532-6. PubMed ID: 591215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone treatment in the prostatic cancer].
    Madsen PO; Pedersen JF; Knuth OE
    Urologe; 1969; 8(6):330-3. PubMed ID: 5405377
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostatic carcinoma: reflections on its natural history, diagnosis, and therapy.
    Schirmer HK
    J Surg Oncol; 1969; 1(2):131-40. PubMed ID: 5406361
    [No Abstract]   [Full Text] [Related]  

  • 13. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
    Blackard CE; Byar DP; Jordan WP
    Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of pretreatment serum nonprotein-bound cortisol and total 17-hydroxycorticosteroid values with survival in patients with prostatic cancer.
    Blackard CE; Byar DP; Seal US; Doe RP
    N Engl J Med; 1974 Oct; 291(15):751-5. PubMed ID: 4369891
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of newly diagnosed metastatic carcinoma of the prostate.
    Elder JS; Catalona WJ
    Urol Clin North Am; 1984 May; 11(2):283-95. PubMed ID: 6428022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of the prostate: treatment comparisons.
    J Urol; 1967 Oct; 98(4):516-22. PubMed ID: 4862213
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of hormones on the growth of virus-transformed hamster prostatic tissue.
    Fraley EE; Paulson DF
    Surg Forum; 1968; 19():544-5. PubMed ID: 4304976
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of prior radical prostatectomy in men with metastatic castration recurrent prostate cancer: a pooled analysis of 9 Cancer and Leukemia Group B Trials.
    Halabi S; Vogelzang NJ; Ou SS; Small EJ
    J Urol; 2007 Feb; 177(2):531-4. PubMed ID: 17222627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
    de Voogt HJ; Pavone-Macaluso M; Smith PH; de Pauw M; Suciu S
    Prog Clin Biol Res; 1988; 260():111-7. PubMed ID: 2966403
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of factors influencing survival of 109 men with carcinoma of the prostate treated conservatively.
    Hand JR
    Trans Am Assoc Genitourin Surg; 1973; 65():84-99. PubMed ID: 4763516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.